In an advance for treating male infertility, researchers transplanted a patient with his own sperm-forming stem cells that ...
The CALEC trial is the first human study of a stem cell therapy to be funded by the National Eye Institute (NEI), a part of the National Institutes of Health (NIH) and was the first stem cell ...
At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...
FLIpping the Switch: Boosting Stem Cell Numbers for Therapies ... blood system over the course of the human lifetime could have implications for the treatment of acute myeloid leukemia and ...
Heart cells grown in space showed stronger survival, better function, and boosted healing traits. Spaceflight changed key ...
Researchers successfully pulled off the first eye stem cell transplants to help heal cornea damage, and the results speak for ...
The study evaluated 14 patients that were treated with cultivated autologous limbal epithelial cells (CALEC) and followed ...
A team of Japanese researchers reports that two out of four patients who received stem cell transplants showed improvements in motor function, marking a potential breakthrough in the treatment of ...
Allogenic Hematopoietic Cell Transplant in Hematological Malignancies: Controversies and Perspective
The Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), since the experiments in rodents in the 50’s, has become a ...
Techniques, treatment protocols ... This blend of biotin, menthol, Panthenol is infused with 13% human stem cell culture to deeply nourish and revitalize. This magnetic tool, shaped like the ...
The CALEC trial is the first human study of a stem cell therapy in the eye in the U.S. Other research collaborators include Jia Yin, MD, Ph.D. and Reza Dana, MD at Mass Eye and Ear; Jerome Ritz ...
An expanded clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea ... stringent quality criteria needed for human transplantation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results